Clinical Trials

Clinical Trials

RSV

  A Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults
  Status: Enrolling Identifier: NCT03026348 
 
  A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization
  Status: Enrolling Identifier: NCT02624947 
 
  A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults
  Status: Ongoing, not recruiting Identifier: NCT02608502 
 
  Safety and Immunigenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year
  Status: Ongoing, not recruiting Identifier: NCT0224776 
 
  RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women
  Status: Ongoing, not recruiting Identifier: NCT02593071 
 
  A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Pediatrics
  Status: Ongoing, not recruiting Identifier: NCT02296463
 
  Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Seniors
  Status: Ongoing, not recruiting Identifier: NCT02266628
 
  RSV F Dose-Ranging Study in Women
  Status: Completed Identifier: NCT01960686
 
  RSV-F Vaccine Dose Ranging Study in Young Women
  Status: Completed Identifier: NCT01704365
 
  Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine
  Status: Completed Identifier: NCT01290419
 
  RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly
  Status: Completed Identifier: NCT01709019
 

Seasonal Influenza

  Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults
  Status: Ongoing, not recruiting Identifier: NCT02307851
 
  A Study to Evaluate the Immune Response and Safety of a Seasonal Influenza VLP Vaccine
  Status: Completed Identifier: NCT01561768
 
  Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza VLP Vaccine
  Status: Completed Identifier: NCT00903552
 
  Evaluate the Safety and immunogenicity of a Seasonal Influenza VLP Vaccine (Recombinant) in Adults
  Status: Completed Identifier: NCT00754455
 
  Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults
  Status: Completed Identifier: NCT01014806
 

Pandemic and Emerging Viruses

Ebola

  Study to Evaluate the Immunogenicity and Safety of an Ebola Virus Glycoprotein Vaccine
  Status: Ongoing, not recruiting Identifier: NCT0237589 
 

Pandemic Influenza

  A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
  Status: Ongoing, not recruiting Identifier: NCT02078674
 
  A(H7N9) VLP Antigen Dose Ranging Study With Adjuvant 1
  Status: Completed Identifier: NCT01897701
 
  A/H5N1 Virus-Like Particle Antigen Dose Ranging Study with Adjuvant 1
  Status: Completed Identifier: NCT01594320
 
  A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2
  Status: Completed Identifier: NCT01596725
 
  Safety, Reactogenicity and Immunogenicity of an H5N1 VLP
  Status: Completed Identifier: NCT00519389
 
  Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine
  Status: Completed Identifier: NCT01072799
 
Please see our Clinical-Stage Pipeline for more information on the vaccine candidates in these clinical trials.

Please see our Press Releases for more information regarding data announcements from these clinical trials.